AAAAAA

   
Results: 1-8 |
Results: 8
Severe prognosis of signet-ring cell adenocarcinoma occurring in Meckel's diverticulum
Authors: Lippe, P Berardi, R Latini, L Bracci, R Cellerino, R
Citation: P. Lippe et al., Severe prognosis of signet-ring cell adenocarcinoma occurring in Meckel's diverticulum, ANN ONCOL, 12(2), 2001, pp. 277-277
A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma
Authors: Bajetta, E Del Vecchio, M Vitali, M Martinetti, A Ferrari, L Queirolo, P Sertoli, MR Cainelli, T Cellerino, R Cascinelli, N
Citation: E. Bajetta et al., A feasibility study using polychemotherapy (cisplatin plus vindesine plus dacarbazine) plus interferon-alpha or monochemotherapy with dacarbazine plus interferon-alpha in metastatic melanoma, TUMORI, 87(4), 2001, pp. 219-222
Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer
Authors: Massacesi, C Bascioni, R Cellerino, R Scartozzi, M Bracci, R Alessandroni, P Antognoli, S Ciavattini, A De Nictolis, M Piga, A
Citation: C. Massacesi et al., Cisplatin, epirubicin and cyclophosphamide (PEC) in the treatment of advanced ovarian cancer, J EXP CL C, 19(1), 2000, pp. 13-16
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group
Authors: Daponte, A Ascierto, PA Gravina, A Melucci, MT Palmieri, G Comella, P Cellerino, R DeLena, M Marini, G Comella, G
Citation: A. Daponte et al., Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma - A multicenter Phase II study of the Southern Italy Cooperative Oncology Group, CANCER, 89(12), 2000, pp. 2630-2636
Intensive versus standard chemotherapy in elderly gastric cancer patients:A retrospective analysis
Authors: Cascinu, S Giordani, P Quattrone, A Catalano, V Antognoli, S Piga, A Catalano, G Cellerino, R
Citation: S. Cascinu et al., Intensive versus standard chemotherapy in elderly gastric cancer patients:A retrospective analysis, GI CANCER, 3(2), 1999, pp. 97-101
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: Aphase II study
Authors: Lippe, P Tummarello, D Monterubbianesi, MC Silva, RR Giuliodori, L Mari, D Santo, A Pasini, E Cetto, GL Rossi, D Porfiri, E Cascinu, S Cellerino, R
Citation: P. Lippe et al., Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: Aphase II study, ANN ONCOL, 10(2), 1999, pp. 217-221
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Authors: Cascinu, S Silva, RR Barni, S Labianca, R Frontini, L Piazza, E Pancera, G Giordani, P Giuliodori, L Pessi, MA Fusco, V Luporini, G Cellerino, R Catalano, G
Citation: S. Cascinu et al., A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD), BR J CANC, 80(10), 1999, pp. 1595-1598
Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Authors: Cascinu, S Frontini, L Comella, G Barni, S Labianca, R Battelli, N Casaretti, R Zonato, S Pirovano, M Catalano, G Cellerino, R
Citation: S. Cascinu et al., Intensive weekly chemotherapy is not effective in advanced pancreatic cancer patients: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD), BR J CANC, 79(3-4), 1999, pp. 491-494
Risultati: 1-8 |